Victory Capital Management Inc. Purchases 78,351 Shares of Humana Inc. (NYSE:HUM)

Victory Capital Management Inc. raised its position in Humana Inc. (NYSE:HUM) by 73.5% during the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 184,937 shares of the insurance provider’s stock after acquiring an additional 78,351 shares during the period. Victory Capital Management Inc. owned about 0.15% of Humana worth $46,920,000 as of its most recent filing with the SEC.

Several other institutional investors have also recently bought and sold shares of the company. FMR LLC raised its holdings in shares of Humana by 23.4% in the third quarter. FMR LLC now owns 3,388,859 shares of the insurance provider’s stock valued at $1,073,387,000 after purchasing an additional 643,291 shares during the last quarter. Thrivent Financial for Lutherans increased its stake in Humana by 55.6% in the 3rd quarter. Thrivent Financial for Lutherans now owns 600,317 shares of the insurance provider’s stock valued at $190,145,000 after buying an additional 214,535 shares during the last quarter. Retirement Systems of Alabama lifted its position in Humana by 735.9% during the 4th quarter. Retirement Systems of Alabama now owns 219,002 shares of the insurance provider’s stock worth $55,563,000 after buying an additional 192,801 shares in the last quarter. Pzena Investment Management LLC lifted its position in Humana by 8.1% during the 3rd quarter. Pzena Investment Management LLC now owns 2,506,250 shares of the insurance provider’s stock worth $793,830,000 after buying an additional 187,903 shares in the last quarter. Finally, Worldquant Millennium Advisors LLC acquired a new position in shares of Humana during the 3rd quarter worth about $50,102,000. Institutional investors own 92.38% of the company’s stock.

Humana Price Performance

NYSE:HUM opened at $259.86 on Friday. Humana Inc. has a 52 week low of $213.31 and a 52 week high of $406.46. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 1.76. The firm’s 50-day simple moving average is $271.80 and its 200 day simple moving average is $283.63. The firm has a market cap of $31.35 billion, a price-to-earnings ratio of 26.12, a P/E/G ratio of 2.05 and a beta of 0.57.

Humana (NYSE:HUM) last released its quarterly earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, beating analysts’ consensus estimates of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. As a group, sell-side analysts predict that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be issued a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a dividend yield of 1.36%. The ex-dividend date is Friday, March 28th. Humana’s dividend payout ratio (DPR) is currently 35.58%.

Wall Street Analysts Forecast Growth

Several research firms recently issued reports on HUM. Barclays upped their target price on Humana from $255.00 to $270.00 and gave the stock an “equal weight” rating in a report on Thursday, February 13th. JPMorgan Chase & Co. dropped their price objective on Humana from $257.00 to $256.00 and set a “neutral” rating on the stock in a research note on Tuesday, February 18th. StockNews.com cut shares of Humana from a “buy” rating to a “hold” rating in a research note on Wednesday. Morgan Stanley dropped their price target on shares of Humana from $301.00 to $285.00 and set an “equal weight” rating on the stock in a research report on Wednesday, February 12th. Finally, Piper Sandler lifted their price objective on shares of Humana from $270.00 to $288.00 and gave the company a “neutral” rating in a research report on Wednesday, January 15th. Twenty investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $285.68.

Insider Buying and Selling

In other Humana news, insider Timothy S. Huval sold 3,703 shares of the stock in a transaction dated Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total transaction of $948,930.78. Following the sale, the insider now directly owns 8,181 shares in the company, valued at $2,096,463.06. This represents a 31.16 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 0.32% of the stock is owned by company insiders.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.